期刊文献+

血小板活化与慢性阻塞性肺疾病肺动脉高压的关系 被引量:5

The relationship between platelet activation and pulmonary hypertension in COPD
暂未订购
导出
摘要 目的:研究血小板活化与慢性阻塞性肺疾病(COPD)肺动脉高压的关系。方法:COPD患者40例,按超声心动图测定的肺动脉压的结果分为COPD肺动脉高压组(A组)20例,COPD肺动脉压正常组(B组)20例。同时选取健康对照者(C组)20例。采用流式细胞仪三色荧光标记法检测3组微量全血血小板活化特异性分子标志物GPⅡb/Ⅲa复合物(PAC-1)、P选择素(CD62P)在血小板表面的阳性表达的百分率。结果:3组的PAC-1阳性表达率分别是(10.95±4.54)%、(4.84±1.70)%、(3.95±0.39)%,A组显著高于B组(P<0.05),B组显著高于C组(P<0.05)。3组的CD62P阳性表达率分别是(12.91±4.32)%、(6.55±2.48)%、(3.69±0.77)%,A组显著高于B组(P<0.05),B组显著高于C组(P<0.05)。相关分析显示,在A组,血小板PAC-1阳性表达率与肺动脉压呈正相关关系(r=0.75,P<0.05),同时血小板CD62P阳性表达率与肺动脉压也呈正相关关系(r=0.79,P<0.05)。结论:血小板活化与COPD肺动脉高压具有十分密切的关系。 Objective To explore the relationship between platelet activation and pulmonary hypertension in COPD. Methods Forty patients with COPD were divided into to pulmonary hypertension group (Group A,n = 20) and normal pulmonary pressure group (Group B, n = 20) according to the findings of Doppler echocardiography. Twenty healthy individuals were selected as control (Group C). The expressions of PAC-1 and CD62P, two specific molecular markers of the activated platelets, were detected by flow cytometry with three-color fluorescence. Results The positive rate of PAC-1 expression was (10.95 ± 4.54)% in Group A, (4.84 ± 1.70)% in Group B, and (3.95 ± 0.39)% in Group C, while that of CD62P expression was (12.91 ± 4.32)%, (6.55 ±2.48)%, and (3.69 ±0.77)%, respectively. The levels of PAC-1 and CD62P expressions in Group A were markedly higher than those in Group B (P 〈 0.05), which in turn were significantly increased than those in Group C (P 〈 0.05). Moreover, the positive rate of PAC-1 expression was positively correlated with pulmonary artery pressure (r = 0.75, P 〈 0.05) in Group A and so was that of CD62P expression (r = 0.79, P 〈 0.05). Conclusion Platelet activation has a very close relation with pulmonary artery hypertension in COPD.
出处 《实用医学杂志》 CAS 2007年第7期981-983,共3页 The Journal of Practical Medicine
关键词 高血压 肺性 肺疾病 慢性阻塞性 血小板活化 CD62P PAC-1 Hypertension, pulmonary Pulmonary disease, chronic obstructive Platelet activation CD62P PAC- 1
  • 相关文献

参考文献10

二级参考文献18

  • 1吴国新,Clin Med J (Engl),1992年,105卷,553页
  • 2吴国新,Nouv Rev Fr Hematol,1992年,34卷,31页
  • 3吴国新,Thromb Haemostas,1991年,65卷,1193页
  • 4吴国新,Nouv Rev Fr Hematol,1990年,32卷,231页
  • 5吴国新,Haemostasis,1993年,23卷,121页
  • 6Peng L,Thromb Res,1997年,87卷,65页
  • 7Murray CJL, Lopez AD. Evidence-based health policy -lessons from the Global Burden of Disease Study. Science, 1996; 274: 740~ 743
  • 8Murray CJL, Lopez, eds. The global burden of disease: Acomprehensive assessment of mortality and disability from diseases, injury and risk factors in 1990 and projected to 2020. Cambridge, MA.:Harvard University Press, 1996
  • 9World Development Indicators Database, Worldbank, 2001
  • 10Siafakas NM, Vemeire P, Pride NB, et al. ERS Consensus Statement. Optimal assessment and management of chronic obstructive puhnonary disease (COPD). Eur Respir J, 1995; 8:1398~1420

共引文献5492

同被引文献46

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部